Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH

Clinical trial NCT04034485 · COMPLETED

Trial details

NCT number: NCT04034485
Sponsor: LIB Therapeutics LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Homozygous Familial Hypercholesterolemia

Start date: 2019-12-07
Primary completion: 2022-09-12
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.